DBV TECHNOLOGIES (EPA:DBV) | Finanzwire

Basculer en Français

9545	Companies
188100	Keywords
119997	Articles
100475	Press releases

Home
Companies
DBV TECHNOLOGIES

BRIEF

published on 12/16/2025 at 22:10, 19 hours 49 minutes ago

DBV Technologies: Encouraging Results from the VITESSE Study on the Peanut Allergy Patch

DBV Technologies Clinical Results Viaskin Peanut Peanut Allergy SPEED Study
BRIEF

published on 12/16/2025 at 22:10, 19 hours 49 minutes ago

DBV Technologies Reports Positive Phase 3 Results for VIASKIN Peanut Patch

Phase 3 Trial Child Health Viaskin Peanut Peanut Allergy BLA Submission
PRESS RELEASE

published on 12/16/2025 at 22:05, 19 hours 54 minutes ago

DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
DBV Technologies reports positive Phase 3 VITESSE Trial results for VIASKIN Peanut Patch in children aged 4-7 years, meeting primary endpoint with notable treatment response rates and safety profile

Phase 3 DBV Technologies Peanut Allergy Viaskin Peanut Patch VITESSE Trial
BRIEF

published on 11/13/2025 at 17:56, 1 month 4 days ago

Artisan Partners exceeds 5% of the capital in DBV Technologies

Biopharmaceutical Shareholding Crossing Thresholds DBV Technologies Artisan Partners
BRIEF

published on 11/12/2025 at 05:55, 1 month 5 days ago

DBV Technologies: Last patient visit in the SPEED trial

Clinical Trial Phase 3 DBV Technologies Peanut Allergy Viaskin® Peanut
PRESS RELEASE

published on 11/12/2025 at 05:50, 1 month 5 days ago

DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
DBV Technologies completes last patient visit in Phase 3 VITESSE Clinical Trial of VIASKIN Peanut Patch for peanut allergic children aged 4-7 years; on track for Q4 data announcement

Clinical Trial DBV Technologies Peanut Allergy VITESSE Phase 3 Viaskin Peanut Patch
BRIEF

published on 11/04/2025 at 22:35, 1 month 12 days ago

DBV Technologies is participating in a healthcare innovation conference

DBV Technologies Viaskin Food Allergies Health Conference EPIT
PRESS RELEASE

published on 11/04/2025 at 22:30, 1 month 12 days ago

DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
DBV Technologies to participate in Guggenheim 2nd Annual Healthcare Innovation Conference with CEO Daniel Tassé at the helm, discussing treatment options for food allergies

Healthcare Innovation DBV Technologies Food Allergies VIASKIN Patch Guggenheim Conference
BRIEF

published on 10/30/2025 at 21:35, 1 month 17 days ago

DBV Technologies Appoints Philina Lee, Ph.D. to Board of Directors

Board Of Directors Biopharmaceutical DBV Technologies Viaskin Peanut Philina Lee
PRESS RELEASE

published on 10/30/2025 at 21:30, 1 month 17 days ago

DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors
DBV Technologies appoints Dr. Philina Lee, Ph.D. as independent director to Board of Directors, bringing extensive biopharmaceutical experience. Company focused on VIASKIN® Peanut for food allergies

Board Of Directors DBV Technologies Food Allergies Viaskin Peanut Dr. Philina Lee

Accesswire

Published on 12/17/2025 at 15:00, 2 hours 59 minutes ago

BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 3 hours 59 minutes ago

UniDoc Completes H3 Health Cube Installation in Italy
Published on 12/17/2025 at 13:35, 4 hours 24 minutes ago

Silver X Mining Announces Grant of Incentive Stock Options and Restricted Share Units
Published on 12/17/2025 at 13:15, 4 hours 44 minutes ago

Aclara Wins UN Global Compact Award for Its Contribution to Local Employment and Suppliers
Published on 12/17/2025 at 13:00, 4 hours 59 minutes ago

Gold Terra Provides a Summary of 2025 Achievements and 2026 Plan

View all ACCESSWIRE

EQS Group

Published on 12/17/2025 at 17:32, 26 minutes ago

EQS-Adhoc: Raiffeisen Bank International AG: Michael Höllerer will succeed Johann Strobl as CEO of RBI on 1 July 2026
Published on 12/17/2025 at 17:29, 30 minutes ago

Correction of a release from 17/12/2025, 16:06 CET/CEST - Updated Conference Call Invitation Links
Published on 12/17/2025 at 16:06, 1 hour 52 minutes ago

Conference Call Invitation
Published on 12/17/2025 at 16:05, 1 hour 53 minutes ago

TCL to Display the Future with Advanced Visual Innovations and AI-Powered Product Portfolio at CES 2026
Published on 12/17/2025 at 16:03, 1 hour 56 minutes ago

1&1 mobile network reaches 25 percent of German households

Les Echos

Published on 12/17/2025 at 17:51, 8 minutes ago

Mr.Bricolage: Completion of the simplification of the Mr.Bricolage Group’s shareholding structure
Published on 12/17/2025 at 17:50, 9 minutes ago

The Council of Paris approves the selection of Dalkia/Eiffage/RATP Solutions Ville consortium for Paris district heating network concession renewal.
Published on 12/17/2025 at 17:45, 14 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2025
Published on 12/17/2025 at 17:45, 14 minutes ago

Adjustment in the timing of the launch of a new share buyback program
Published on 12/16/2025 at 20:10, 21 hours 48 minutes ago

donation of shares of Seval, member of the Feuillet family concert

View all LES ECHOS COMFI WIRE